Wednesday, May 18, 2011
Taking Diabetes Drug Actos Could Lead to a Higher Risk of Developing Bladder Cancer
More research is needed but over a period of five years, 138 instances of bladder cancer were reported from patients taking diabetes medications. Over 28 of these patients were taking Actos (pioglitazone). This suggests a "disproportionate risk" in comparison with other anti-diabetics, said study author Dr. Elisabetta Poluzzi of the University of Bologna in Italy."Disproportion is indicative of possible risk," Poluzzi added, "not of an actual risk."
The FDA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment